Contract research, development and manufacturing organisation Aragen Life Science has secured a $100 million investment from Asia healthcare-focused private equity fund Quadria Capital. Quadria will acquire a minority stake in Aragen, at an approximate valuation of $1.4 billion, primarily through a fresh capital infusion, with a small portion from the sale of shares by existing investors, Aragen said on Monday. …
